Skip to main content
    C

    CVRx Inc (CVRX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.61
    +0.01 (+0.92%)

    Market Cap: $17.30M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    CVRx Inc (CVRX) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    CVRX reported revenue of $56.65M for the fiscal year ended Dec 31, 2025, up 10.4% from the year before. That year, net income was -$53.31M with a net margin of -94.1%, operating cash flow was -$40.17M and free cash flow was -$40.75M. The quarter ended Sep 30, 2026 had revenue of $13.83M and net income of -$14.16M.

    Revenue and Margins

    The operating margin was -90.5% in the fiscal year ended Dec 2025. Over the 6 years to Dec 2025, revenue grew from $6.26M, a compound annual rate of 44.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$56.65M+10.4%85.3%-90.5%-94.1%
    Dec 2024$51.29M+30.5%83.8%-116.0%-116.9%
    Dec 2023$39.30M+74.9%84.1%-109.7%-104.8%
    Dec 2022$22.47M+72.4%77.8%-189.3%-184.4%
    Dec 2021$13.04M+115.4%72.1%-199.2%-330.5%
    Dec 2020$6.05M-3.3%76.2%-190.2%-233.1%
    Dec 2019$6.26MN/A73.1%-162.9%-233.9%
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$56.65M$51.29M$39.30M$22.47M$13.04M$6.05M$6.26M
    Cost of revenue$8.31M$8.33M$6.26M$5.00M$3.64M$1.44M$1.68M
    Gross profit$48.34M$42.96M$33.04M$17.47M$9.40M$4.61M$4.57M
    Research and development$11.13M$11.13M$11.63M$9.95M$7.50M$6.41M$8.66M
    Operating income-$51.27M-$59.49M-$43.10M-$42.53M-$25.97M-$11.51M-$10.19M
    Net income-$53.31M-$59.97M-$41.20M-$41.43M-$43.08M-$14.11M-$14.63M
    EBITDA-$46.50M-$54.69M-$38.58M-$40.72MN/A-$11.19MN/A
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$13.83M$15.71M$14.77M$16.02M$14.69M$13.59M$12.35M$15.34M$13.37M$11.81M$10.77M$11.30M
    Gross profit$12.00M$13.72M$12.88M$13.82M$12.75M$11.45M$10.31M$12.77M$11.13M$9.91M$9.15M$9.59M
    Operating income-$13.04M-$13.02M-$12.16M-$11.18M-$12.27M-$14.38M-$13.44M-$10.27M-$13.01M-$13.97M-$22.23M-$9.66M
    Net income-$14.16M-$14.04M-$13.12M-$11.93M-$12.87M-$14.74M-$13.77M-$10.65M-$13.10M-$14.03M-$22.19M-$9.16M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded long-term debt of $49.51M by $26.19M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$104.79M$133.41M$115.23M$124.94M$152.55M$64.78M$29.11M
    Current assets$101.65M$129.81M$112.09M$122.88M$151.10M$64.34M$28.91M
    Cash and equivalents$75.71M$105.93M$90.57M$106.19M$142.07M$59.11M$25.74M
    Total liabilities$65.47M$62.36M$39.28M$15.76M$6.59M$28.03M$308.15M
    Short-term debtN/A$282.00K$231.00K$222.00KN/AN/AN/A
    Long-term debt$49.51M$49.27M$29.22M$6.75M$0$19.28M$18.99M
    Shareholder equity$39.32M$71.06M$75.95M$109.18M$145.96M-$293.24M-$279.04M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$87.61M$92.28M$99.73M$104.79M$111.33M$119.56M$129.59M$133.41M$127.67M$95.98M$106.17M$115.23M
    Total liabilities$73.79M$72.33M$70.62M$65.47M$63.27M$61.63M$60.23M$62.36M$62.49M$40.73M$39.91M$39.28M
    Cash and equivalents$58.75M$64.59M$72.30M$75.71M$85.12M$95.03M$102.67M$105.93M$100.16M$70.40M$80.11M$90.57M
    Shareholder equity$13.82M$19.95M$29.11M$39.32M$48.05M$57.93M$69.36M$71.06M$65.18M$55.25M$66.26M$75.95M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow-$40.17M-$39.14M-$39.02M-$42.68M-$27.73M-$16.10M-$12.79M
    Capital expenditures$580.00K$1.36M$591.00K$685.00K$1.18M$311.00K$106.00K
    Free cash flow-$40.75M-$40.51M-$39.61M-$43.36M-$28.91M-$16.41M-$12.89M
    Investing cash flow-$580.00K-$1.36M-$591.00K-$685.00K-$1.18M-$311.00K-$106.00K
    Financing cash flow$10.52M$55.87M$23.98M$7.49M$111.88M$49.78M$29.55M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$10.90M-$8.83M-$12.16M-$9.76M-$9.71M-$7.94M-$12.77M-$8.01M-$10.41M-$9.83M-$10.90M-$7.84M
    Capital expenditures$98.00K$112.00K$122.00K$68.00K$295.00K$103.00K$114.00K$52.00K$37.00K$355.00K$917.00K$169.00K
    Free cash flow-$10.99M-$8.94M-$12.29M-$9.83M-$10.00M-$8.04M-$12.88M-$8.06M-$10.45M-$10.19M-$11.81M-$8.01M
    Last 12 quarters

    Frequently Asked Questions About CVRX

    What is CVRX's annual revenue?

    CVRX reported revenue of $56.65M for the fiscal year ended Dec 31, 2025.

    How fast is CVRX's revenue growing?

    Revenue was up 10.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 36.1%.

    Is CVRX profitable?

    No. CVRX reported net income of -$53.31M for the fiscal year ended Dec 31, 2025, with a net margin of -94.1%.

    How much free cash flow does CVRX generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$40.17M minus capital expenditures of $580.00K produced free cash flow of -$40.75M.

    How much debt does CVRX have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $49.51M and cash and equivalents of $75.71M.